Has Anyone Actually Died From Heart Ablation?

Deaths from cardiac ablation have been documented since the procedure’s earliest days, but they are rare. Across large studies involving tens of thousands of patients, the rate of death directly caused by the procedure itself falls in the range of roughly 1 in 1,000 to 1 in 2,000 cases. The honest answer is more nuanced than a simple yes or no, because the risk depends heavily on what type of arrhythmia is being ablated, how sick the patient already is, and even where the procedure takes place.

How Often People Die After Ablation

Several large studies have tried to pin down the mortality rate, and the numbers vary depending on how you count. A study of nearly 6,700 atrial fibrillation ablation patients found that the 90-day mortality rate from all causes was about 0.2%, but when researchers looked only at deaths that were directly caused by the procedure itself, the rate dropped to 0.06%, or roughly 1 in 1,700 procedures.¹ That distinction matters: most people who die within a few months of ablation die from something unrelated to the procedure. In that study, about three-quarters of deaths within 90 days had no direct connection to the ablation.

A larger analysis using national data put the early mortality figure higher, at about 0.46%, and found that over half of those deaths happened during hospital readmission rather than during the initial procedure or recovery.² The median time from ablation to death was roughly 12 days, suggesting that many fatal outcomes are delayed rather than occurring on the table. That same study flagged an unsettling trend: quarterly early mortality rates appeared to climb between 2010 and 2015. One likely explanation is that doctors have expanded ablation to sicker, older patients over time, which raises the population-level risk even if the procedure itself hasn’t become more dangerous.

A separate study looking at over 100,000 atrial fibrillation ablations found a 30-day mortality rate of about 0.6%, but with a dramatic split between patients who had the procedure as outpatients versus those already hospitalized for another reason. Outpatient ablation carried a 30-day mortality rate of just 0.2%, while inpatient ablation carried a rate of 2.4%.³ That gap almost certainly reflects the fact that hospitalized patients tend to be sicker at baseline, not that the procedure is somehow more dangerous when done in a hospital bed.

What Actually Kills People

An international survey that pooled data from more than 45,000 atrial fibrillation ablation procedures found 32 deaths, working out to roughly 1 per 1,000 patients. The leading causes were cardiac tamponade (fluid compressing the heart after a puncture), stroke, and atrioesophageal fistula, an abnormal connection that forms between the heart and the esophagus.⁴ In the more recent study of nearly 6,700 patients, the single most common cause of early death was classified as sudden death, followed by stroke, respiratory failure, and atrioesophageal fistula, each accounting for a roughly similar share of the small number of fatal cases.¹

A large German analysis of more than 43,000 ablation procedures for various arrhythmias found in-hospital death in 0.2% of all procedures, but the rate adjudicated as truly ablation-related was lower: about 0.03% for atrial fibrillation ablation and 0.04% for atrial flutter ablation.⁵ The rest of the deaths in that study happened in patients who were already gravely ill or had complications unrelated to the ablation itself. Teasing apart “died after ablation” from “died because of ablation” is a persistent challenge in this field, and the distinction explains much of the variation across published mortality rates.

Atrioesophageal Fistula, the Most Feared Complication

Of all the ways an ablation can go fatally wrong, the one that keeps electrophysiologists up at night is atrioesophageal fistula. During atrial fibrillation ablation, the catheter delivers energy to the back wall of the left atrium, which sits right against the esophagus. If the heat (or cold, depending on the energy source) penetrates too deeply, it can damage the esophageal wall and eventually create a hole between the two structures. The result can be catastrophic: air or bacteria from the esophagus entering the bloodstream, causing brain air embolism, massive bleeding, or septic shock.⁶

This complication is extremely rare, but when it does happen, it kills a large share of the people who develop it. A systematic review of reported cases found mortality rates between roughly 40% and 80%, depending on how aggressively and quickly it was treated. Patients who underwent surgical repair of the fistula had meaningfully better odds of surviving than those managed without surgery.⁷ The tricky part is that the fistula doesn’t typically show up immediately. It can develop days to weeks after the procedure, often presenting with fever, chest pain, trouble swallowing, or neurological symptoms that may initially be mistaken for something else. That delay in recognition is part of what makes it so lethal.

Stroke After Ablation

Stroke is another potentially fatal complication, though it has become less common as anticoagulation practices have improved. A global registry collecting data from 204 centers on more than 335,000 ablation procedures recorded embolic events (mostly strokes) at a rate of about 0.16%. Among patients who had a stroke or other embolic event, about 3% died and roughly a third were left with lasting neurological deficits at three months.⁸ Periprocedural stroke risk has been reported at around 0.3% in anticoagulated patients.⁹

One challenge with ablation-related stroke is that the posterior circulation of the brain, which supplies the brainstem and visual cortex, can be preferentially affected. Symptoms like dizziness, visual disturbances, or difficulty coordinating movement can be subtle and initially overlooked in the post-procedure setting. Recognition of this pattern has improved, and most centers now use standardized neurological assessments after ablation, but delayed diagnosis remains a concern.

Cardiac Tamponade and Perforation

Cardiac tamponade, where blood or fluid collects around the heart and compresses it, is the most common acute life-threatening complication during ablation. In the large German registry, tamponade occurred in about 0.7% of all ablation procedures.⁵ Fortunately, most cases are survivable when recognized and treated promptly. In a study specifically looking at ventricular arrhythmia ablation, cardiac tamponade complicated about 1.5% of procedures, but all patients survived to hospital discharge after emergency drainage and, in some cases, surgical repair.¹⁰

A similar picture emerged from another study of ventricular perforation during ablation, where 1% of procedures resulted in a perforation requiring emergency treatment, but again, all patients survived.¹¹ Tamponade is serious and requires immediate action in the catheterization lab, but electrophysiology teams train extensively for this scenario. It becomes lethal mainly when recognition is delayed or when the patient has other factors that make rescue difficult.

Why Ventricular Ablation Carries Higher Risk

Not all ablations are created equal. The risk profile depends heavily on which arrhythmia is being treated. Ablation for supraventricular tachycardia, one of the most common and straightforward types, carries a major complication rate under 1%. Atrial fibrillation ablation has a higher complication rate, typically in the range of 1% to 5%. But ventricular tachycardia ablation, especially in patients who already have structural heart disease, sits at the top of the risk ladder. In one prospective evaluation, ventricular tachycardia ablation in patients with structural heart disease carried a 6% major complication rate, compared to 0.8% for supraventricular tachycardia ablation.¹²

The mortality difference is similarly stark. In the large German registry, the in-hospital ablation-related mortality rate for ventricular tachycardia was 0.42%, more than ten times the rate for atrial fibrillation ablation.⁵ This makes sense when you consider the patient population. People undergoing ventricular tachycardia ablation often have severely weakened hearts, prior heart attacks, or cardiomyopathy, and the ablation itself involves working on thicker, more muscular heart tissue with a higher perforation risk. The procedure is longer, the anatomy is more complex, and the margin for error is thinner.

Who Is Most at Risk

Beyond the type of ablation, certain patient characteristics predict a higher chance of complications and death. Older age, more comorbidities, and kidney dysfunction have all been identified as independent risk factors for in-hospital complications and mortality.¹³ A serum creatinine level above 1.5 mg/dL, a marker of impaired kidney function, was associated with roughly two and a half times the odds of a major complication.¹²

Operator and center experience also appear to matter, though this is harder to quantify precisely. An editorial accompanying one of the major mortality studies explicitly emphasized that experience matters when it comes to mortality rates in atrial fibrillation ablation.¹⁴ High-volume centers that perform hundreds of ablations a year tend to have lower complication rates than facilities where the procedure is done occasionally. This is consistent with what we see across many types of interventional procedures and surgeries. If you’re considering ablation, the track record of your specific center and operator is probably a more meaningful data point than national averages.

Ablation Versus Staying on Medications

Any discussion of ablation risk has to be weighed against the alternative. For most people with atrial fibrillation, the main alternative to ablation is long-term use of antiarrhythmic drugs, which carry their own risks including organ toxicity, dangerous heart rhythm side effects, and interactions with other medications. The CABANA trial, the largest randomized comparison of ablation versus drug therapy for atrial fibrillation, found that all-cause mortality at four years was similar between the two groups: about 4.7% for ablation versus 5.3% for drug therapy, a difference that was not statistically significant.¹⁵

A meta-analysis that pooled results from randomized trials found a roughly 30% reduction in all-cause mortality with ablation compared to medical therapy, with the benefit driven particularly by patients who had reduced heart function.¹⁶ In other words, for the very population that faces higher procedural risk, ablation may also offer the greatest long-term survival benefit compared to staying on drugs alone. This tension between short-term procedural risk and long-term mortality benefit is at the core of every ablation decision.

Is Newer Technology Making It Safer

Ablation technology has evolved considerably. The oldest approach uses radiofrequency energy to create precise heat lesions in heart tissue. Cryoballoon ablation, which freezes rather than burns, became a popular alternative. The newest entrant is pulsed field ablation, which uses brief, intense electrical fields to disrupt heart cells without relying on thermal energy at all. The appeal of pulsed field ablation is its tissue selectivity: it targets heart muscle while largely sparing the esophagus, nerves, and blood vessels nearby.

A systematic review and meta-analysis comparing pulsed field ablation to cryoballoon ablation found that overall complication rates were lower with pulsed field technology, about 3.1% versus 5.6%.¹⁷ Phrenic nerve injury, a known complication of cryoballoon ablation that can temporarily paralyze the diaphragm, was virtually eliminated with pulsed field ablation (0.01% versus 1.84%). When the analysis was restricted to major complications only, however, the difference between the two technologies narrowed and was no longer significant. No atrioesophageal fistulas were reported with either technology in the reviewed studies, which is encouraging but may reflect the relatively small total number of procedures studied so far.

Non-Fatal Complications Worth Knowing About

Death is the extreme end of the complication spectrum, but plenty of non-fatal complications deserve attention. Phrenic nerve injury, for example, occurs when energy delivery near the right pulmonary veins damages the nerve that controls the diaphragm. A multicenter study found it in about 0.5% of ablation procedures. Most patients recovered, but it took an average of four months of respiratory rehabilitation, and about a third of affected patients had persistent nerve damage at long-term follow-up.¹⁸ This kind of injury won’t kill you, but it can leave you chronically short of breath, which significantly affects quality of life.

Vascular complications at the catheter entry site in the groin, including bleeding, hematoma, and pseudoaneurysm, are among the most common complications overall. In the German registry, femoral vascular complications requiring surgical repair occurred in about 0.4% of ablation procedures.⁵ These are rarely life-threatening but can extend hospital stays and recovery time.

Radiation Exposure and Long-Term Cancer Risk

Ablation procedures have traditionally relied on fluoroscopy, which exposes both patient and operator to radiation. While individual exposures are modest, the procedure can involve substantial fluoroscopy time. One study estimated that 60 minutes of fluoroscopy during radiofrequency ablation carries a mean excess lifetime risk of a fatal cancer of about 0.03%, with lung cancer being the most likely type.¹⁹ That’s a small number, but it’s not zero, and it adds context for patients who may need repeat procedures. Modern labs increasingly use 3D mapping systems that reduce or eliminate the need for fluoroscopy, though the technology isn’t universally available.

When an Ablation Death Ends Up in Court

Fatal outcomes occasionally lead to medicolegal investigations, and the autopsy findings can be illuminating. In one published case, a 57-year-old man underwent ablation for persistent atrial fibrillation and atrial flutter, then developed ventricular fibrillation two hours after the procedure. Despite resuscitation, he died 26 days later from pneumonia acquired in the hospital. An autopsy ordered by prosecutors revealed that the man had systemic amyloidosis, a condition in which abnormal proteins infiltrate organs including the heart, which had never been diagnosed before the procedure.²⁰ Cases like this underscore how difficult it can be to assign blame: the ablation may have destabilized a heart that was already far sicker than anyone realized.

In an earlier published case from the mid-1980s, a patient died suddenly after catheter-induced ablation of the heart’s electrical junction. The autopsy revealed extensive pre-existing damage to the conduction system, including severe fatty infiltration and chronic inflammatory changes, along with degenerative valve disease.²¹ These post-mortem reports are a reminder that ablation deaths often occur in hearts that were already severely compromised, which complicates any simple narrative about the procedure being “the cause.”

Long-Term Mortality After You Survive the Procedure

If the short-term procedural risk is the cliff everyone worries about, the long-term outlook is more reassuring. A recent study following patients after atrial fibrillation ablation found that all-cause mortality at one year was about 0.7%, and at three years about 1.7% to 2.0%, with no significant difference between patients who had paroxysmal versus persistent atrial fibrillation.²² These rates are driven primarily by the underlying heart disease and other health conditions rather than by delayed consequences of the ablation itself. In the context of a population that has atrial fibrillation and is therefore already at elevated cardiovascular risk, these are relatively low numbers.

The picture that emerges from all of this data is a procedure that carries real but small risks of death, with the most dangerous scenarios being rare complications like atrioesophageal fistula, stroke, and cardiac tamponade. The risk is concentrated in sicker patients and more complex procedures, particularly ventricular tachycardia ablation in people with structural heart disease. For the typical atrial fibrillation patient undergoing an elective outpatient ablation at an experienced center, the directly procedure-related mortality risk is on the order of a few per ten thousand, a number that most people weighing their options would consider acceptably low.